Our History

Landmarks in Boehringer Ingelheim UK's History 2000-2010

2001

Surgeons in Louisville successfully implanted an artificial heart into a man.

£14 million was spent improving the site in Bracknell and the number of employees grew to 750.

Metalyse was introduced.

2002

2002 - Duke of York visited

Virtual ultrasound was invented to allow 'parents to be' to see 3D images of their developing child.

Spirivia was introduced together with Pfizer.

The Duke of York visited us to celebrate 40 years of being in the UK.

Antistax was introduced.

2004

The first scientific evidence was unveiled showing that a new 'vaccine' against cocaine addiction could help users to quit by preventing them from getting high.

Yentreve was introduced together with Lilly.

Mirapexin became available from Boehringer Ingelheim UK.

2005

Our number of employees has grown to approximately 1000 and we have introduced our second product with Lilly, Cymbalta.

2008

Pradaxa was introduced to the UK.

2010

Flomax Relief® is made available without a prescription in pharmacy for men.

The Corporation celebrates its 125^th Jubilee year

1985-2000